Microbiota Research Articles

Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial

BackgroundAntipsychotic drugs may have adverse effects on the components of metabolic syndrome. Previous studies have shown that changes in the intestinal microbiome are associated with metabolic disturbances in patients with schizophrenia. The objective of this study was to determine the effects of synbiotics on the components of metabolic syndrome as primary outcomes in patients with schizophrenia. Secondary outcomes were HbA1c, insulin resistance, LDL-c, and anthropometric measurements.MethodsIn this double-blind, placebo-controlled trial, seventy patients with schizophrenia receiving antipsychotic drugs who had at least two criteria of metabolic syndrome were randomly divided into two groups to receive either two capsules of a synbiotic supplement or a placebo daily for 8 weeks. Anthropometric indices and biochemical parameters were measured at baseline and after the intervention.ResultsFifty-five patients completed the study. The synbiotic supplement significantly decreased waist circumference and HbA1C compared to placebo (-2.66 ± 4.20 vs. 3.03 ± 4.50 and − 0.26 ± 0.54 vs. 0.20 ± 0.75, respectively). Although BMI did not change significantly in the synbiotic + antipsychotic group, it increased in the placebo + antipsychotic group (-0.37 ± 1.00 vs. 0.61 ± 1.09 P < 0.5). LDL-c and triglyceride (TG) levels decreased significantly in the synbiotic + antipsychotic group, but the change was not significantly different from that of the placebo + antipsychotic group. FBS, HDL-c, systolic and diastolic blood pressure, insulin resistance, and total cholesterol were not significantly different between the two groups after intervention.ConclusionSynbiotic supplement may decrease waist circumference, HbA1c, LDL and TG and prevent BMI increase in patients receiving antipsychotic drugs.Trial registrationIranian Registry of Clinical Trials (IRCT Number: IRCT20090901002394N45), Date: 26-12-2019.

Growth, biochemical indexes, and intestinal microbiota response of red tilapia (Oreochromis spp.) under different densities and feeding frequencies in the land-based aquaculture tank

Red tilapia (Oreochromis spp.) has been favored by farmers in recent years because of its superior growth performance and competitive market price, but there is a lack of experimental data related to growth and health of red tilapia in land-based aquaculture tanks. In this study, red tilapia (initial weight 27.62 ± 2.43 g) was cultured with three stocking densities (30, 40, or 50 fish/m3, named 30F,40F and 50F) in the culture mode for 60 days, including two feeding frequencies (2 or 3 times/day, named 2 T and 3 T), and various growth and metabolic parameters were assessed along with the intestinal microbiome analysis. The 30 fish/m3 groups achieved the better weigh gain rate and specific growth rate (p < 0.05). The growth rate and condition factor of 40F groups were close to those of 30F groups, the yield of 40F groups were not significantly different from that of 50F groups (p > 0.05), and it had the highest survival rate (p < 0.05). The 3 T groups has a higher growth rate and yield but also has a higher rate of feed conversion (p < 0.05). The 30F groups had higher lipase levels, but a higher fat content in this group, more lipids were observed in the liver, and resulted in higher blood glucose levels (p < 0.05). The 40F groups showed healthier physiological and biochemical indicators, as its total cholesterol, lysozyme and antioxidant enzymes levels were similar to those of the 30F groups (p > 0.05), alkaline phosphatase, amylase and trypsin levels were higher than those of the other groups, and aspartate transaminase levels were the lowest (p < 0.05). The 50F groups had higher cortisol, alanine transaminase and malondialdehyde levels, lower lysozyme and digestive enzyme activities, and blood cell infiltration in the liver (p < 0.05). In terms of different feeding frequencies, the 3 T groups had higher crude protein content, catalase and total superoxide dismutase levels, wider villus width and lower blood glucose level, while the 2 T groups had higher triglyceride, total cholesterol, lysozyme, alkaline phosphatase and some digestive enzymes activities (p < 0.05). From the perspective of intestinal microbiota. The 40F groups had a better intestinal flora, and 40F-3T groups observed a better balance of flora, while 40F-2T groups had more digestion-related flora. Considering the growth rate, health status, and yield, the optimum culture condition was determined to be stocking density of 40 fish/m3, and feedings 3 times/day were recommended. The experiment provided theoretical basis and experimental data for red tilapia culture in land-based aquaculture tank mode.

Evaluating the Therapeutic Efficacy of Lactobacillus Strains in the Management of Ulcerative Colitis: An Overview of Recent Advances.

Ulcerative Colitis (UC) known as a sub-category of Inflammatory Bowel Diseases (IBD) is a longterm condition that causes inflammation, irritation, and ulcers in the colon and rectum. Though the precise pathogenesis of UC is not fully understood yet, impaired immune responses and imbalanced intestinal microbiome composition have been regarded as two main key players in colitis pathobiology. As conventional treatments are challenged with limitations and side effects, finding a new therapeutic approach has gained increasing attention. Probiotic bacteria with multifunctional health-promoting properties have been considered novel therapeutic options. There is strong evidence indicating that probiotics exert their therapeutic effects mostly by regulating immune system responses and restoring gut microbiome homeostasis. These results validate the rationale behind the clinical application of probiotics in UC management whether prescribed alone or in combination with conventional therapy. This article explores the pathogenesis of UC, concentrating on the influence of immune dysregulation and intestinal microbiome imbalances. Also, it reviews recent in vitro, in vivo, and clinical studies that have demonstrated the efficacy of Lactobacillus species in decreasing UC symptoms by modifying immune responses, restoring gut microbiota balance, and promoting intestinal barrier function.

Effects of Bacteriocin Extracted from Lactobacillus plantarum on Treatment-Resistant Escherichia coli Bacteria Isolated from Humans and Livestock

Background: Lactic acid bacteria (LAB) are among the most common probiotics and play a significant role in promoting health within the human intestinal microbiota. Their protective functions in the intestine include producing antimicrobial compounds, regulating the balance of the intestinal microbiome, and more. Objectives: This study aims to investigate the antimicrobial effects of bacteriocin extracted from Lactobacillus plantarum (L. plantarum) on Escherichia coli (E. coli) strains that cause treatment-resistant urinary tract infections (UTIs) in humans and mastitis in livestock. Methods: Twenty E. coli isolates were obtained from patients with UTIs and cows with mastitis. After culturing the samples on Eosin-methylene blue, McConkey agar, and blood agar, the strains were identified using biochemical tests. Bacteriocin produced by L. plantarum ATCC8014 was extracted, and its concentration was measured using the Bradford method. The antimicrobial effect of the bacteriocin was assessed using the broth microdilution method to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Additionally, the bacteriocin's antimicrobial activity was evaluated through three repetitions of disk diffusion and agar well diffusion methods. Results: The findings revealed that the MIC and MBC concentrations for all human and animal strains were 13.38 μg/mL and 26.76 μg/mL, respectively. Notably, two animal samples (No. 3 and No. 10) and one human sample (No. 6) showed lower MIC and MBC concentrations compared to the other samples and the standard E. coli sample. However, all strains were resistant to bacteriocin in the disk diffusion and agar well diffusion methods. Conclusions: The data indicate a high risk of increasing treatment-resistant E. coli strains in UTIs and livestock, which could pose a significant threat to public and animal health. Therefore, it is essential to further investigate the effects of different bacteriocins on these resistant strains, in conjunction with antibiotic therapies.

A multi-omics approach reveals the changes in the gut microbiome and metabolism of large yellow croaker (Larimichthys crocea) by dietary supplementation with Bacillus

The intestine serves as the primary site for nutrient absorption in animals. Research in gut biology is increasingly focused on understanding its correlation with the microbiome, specifically by employing probiotics in diets to enhance gut health and stimulate animal growth. In this study, we isolated two Bacillus species (Bacillus halophilus and Lysinibacillus sphaericus) from the intestinal tract of a large yellow croaker and investigated their roles as dietary supplements, assessing their impact on intestinal microbial composition and their efficacy in large yellow croaker growth and immunity. These functions are intrinsically linked to the growth and immune response of large yellow croaker. Our investigation included a comprehensive analysis of various omics results derived from intestinal content samples, encompassing 16S rRNA sequencing and non-targeted metabolomics. These analyses were combined with assessments of differences in immune functionalities observed in the liver and head kidney, aiming to understand the interaction between the two Bacillus species, intestinal microorganisms, and host metabolism. Our findings demonstrated several significant outcomes: (1) Supplementation with two Bacillus species induced considerable alterations in the intestinal microbiome, particularly in the suppression of Vibrionaceae among juvenile large yellow croaker. (2) The influence of pathogenic bacteria such as Vibrio on intestinal health is not solely associated with their characteristics but also closely linked to their relative abundance in the intestine. (3) Distinct dietary groups further influenced changes in the metabolome profile by impacting the intestinal microbiota structure in juvenile large yellow croaker, thereby influencing various metabolites such as amino acids, terpenes, bile acids, and steroids. (4) Differences in the composition of intestinal microbiota among different feed types significantly affected individual antioxidant functionalities, impacting the morphology and immune capabilities of immune organs like the liver. Exploring intricate host-microbiome interactions using multi-omics approaches can provide a better assessment of probiotics' functional potential. Our results revealed that Lysinibacillus sphaericus enhanced intestinal development, increased antioxidant enzyme activity, and facilitated the growth of large yellow croaker.

Carlos Asensio and the dawn of molecular microbial ecology.

At near 50years of the discovery of microcins, this article highlights the pivotal-but under-recognised-influence of Spanish biochemist Carlos Asensio (1925-1982) in contemporary microbiology, featuring the epistemological, sociological, and cultural impact of his scientific achievements. At a time when the intestinal microbiome is central to current biomedical research, it is due to emphasise his role in the establishment of new scientific fields that are now considered fundamental. Despite his premature death at the peak of his conceptual and experimental creativity, many of his ideas about microbial communication in complex communities inspired a generation of researchers and opened new topics reach to this day. Asensio was also a trailblazer in Spain, advocating for fundamental research within the socio-economic context of his time. He foresaw the shift towards what is now termed the knowledge-based bioeconomy, recognised the need for multidisciplinary research teams, and advocated integration science into societal and political agendas. These facets became evident during his research on microcins, low molecular weight bioactive compounds produced by enterobacteria. These molecules were hypothesised as mediators of microbial interactions in the human gut and were considered potential new antibiotics and even antitumoral agents. His research mobilised young talent and attracted unprecedented resources in Spain during the late 1970s-early 1980s. It underscored the medical value of microbial ecology and exemplified the benefits of collaboration between academia and industry. Asensio played a pivotal role in the emergence of molecular microbial ecology as a research discipline and its foundational and applied significance in biotechnology.

Changes in the intestinal microbiome of the preterm baby associated with stopping non-invasive pressure support: a prospective cohort study

BackgroundIntestinal dysbiosis is implicated in the pathogenesis of necrotising enterocolitis and late-onset sepsis in preterm babies. The provision of non-invasive positive pressure ventilation is a common clinical intervention in preterm...

A-239 Cxcl10 induced gut dysbiosis exacerbates acute lung injury and secondary infection in influenza by inhibiting il22

Abstract Background Secondary infections are the most cause of severe pulmonary injury and death in influenza. CXCL10, known as interferon γ-induced protein 10(IP-10), is highly upregulated in response to IFN-γstimulation during influenza. Previous studies show that CXCL10 contributes to bacteria co-infections and worse finales in influenza. However, the underlying mechanisms by which CXCL10 facilitate secondary infections remains unclear. Emerging evidences show that influenza virus infections disturb the composition and function of gut microbiota, which in turn influences the infection process. Herein, we aimed to explore whether CXCL10 could affect the progress of influenza infection and secondary infection in a gut microbiota dependent manner. Methods CXCL10 knockout mice were used to determine the role of CXCL10 in staphylococcus aureus co-infection after influenza A virus (IAV) infection. Lung tissues from CXCL10 knockout mice were collected for Transcriptomics sequencing. Feces from mice and clinicals including IAV patients and healthy individuals were collected for Metagenomic sequencing. Paired serum samples were collected for Metabolomic sequencing. QRT-PCR was performed to determine the expression of inflammatory factors in lung tissues from CXCL10 knockout mice. Elisa assays were used to measure the serum expression levels of CXCL10 and IL22. Flow cytometry was applied to detect the proportion of IL22+ cells. Fecal microbiota transplantation (FMT) was applied to confirm that CXCL10 plays an adverse role in acute lung injury and staphylococcus aureus co-infection after IAV infection by disrupting intestinal microbiome homeostasis. Results CXCL10 aggravated acute lung injury and promoted staphylococcus aureus coinfection after IAV infection. Transcriptomics sequencing results suggests improved cell membrane integrity and regeneration of epithelial cells after IAV infection in CXCL10 knockout mice with an upregulation of integrity proteins. CXCL10 knockout significantly increased the expression levels of IL22 without influencing virus duplication. rh-IL22 protects lung epithelial cell from staphylococcus aureus co-infection in influenza and increased the expression of tight junction proteins. The gut microbiome shows different structures between wild type mice and knockout mice, as well as clinical samples according to serum CXCL10 expression levels. We found some genera were markedly increased in knockout mice and patients with low serum CXCL10 expression levels including Lactobacillus, Lachnospiraceae, Oscillibacter, Odoribacter, Eubacterium. FMT from patients with low serum CXCL10 levels and healthy individuals ameliorating lung pathological damage. Conclusions This study interpreted that CXCL10 exacerbates acute lung injury and secondary infection in influenza by inducing gut dysbiosis, suggesting that balancing the gut flora could be assistant treatments to protect from acute lung injury and secondary infections in influenza. And IL22 may be a potential mediating factor between gut-lung axis to improve epithelial integrity.

Replacing sea mud with attachment of suspension cage can improve growth and gut health for sea cucumber Apostichopus japonicus

During the suspension cage culture procedure, a substantial quantity of attachments from the suspension cage will amass in the tidal flats, resulting in environmental pollution and resource wastage. The aim of the present study was to explore the feasibility of using attachments of suspension cage (ASC) as a raw feed material for sea cucumbers. Different ASC concentrations (0, 25, 50, 75, and 100%) were used in sea cucumber (Apostichopus japonicus) fed for 60 d. Replacing sea mud with 50% ASC significantly improved sea cucumber growth, reduced the feed coefficient, significantly increased the activity of intestinal digestive enzymes, improved the activities of acid phosphatase and alkaline phosphatase, improved the intestinal structure, and enriched intestinal microbiome diversity (P&amp;lt;0.05). Replacing sea mud with 75% and 100% ASC significantly improved sea cucumber total antioxidant capacity and total superoxide dismutase (P&amp;lt;0.05).Furthermore, expressions of c-myc gene, mapk-7 gene and fgfr-1 gene, which all three growth genes, significantly increased in the 50% ASC treatment compared to that in the control; whereas, that of gdf-8 gene, a negative growth regulator, was inhibited (P&amp;lt;0.05). Based on the quadratic regression analysis for the weight gain rate, the appropriate levels of ASC substitution were estimated as to be 44.28%. The results suggested the potential of ASC as a new raw feed material for sea cucumbers.

The intestinal microbiome, but not clinical aspects of inflammatory bowel disease, is impacted by lactose malabsorption compared to lactose digestion in children

BackgroundDietary exclusion of lactose from patients with inflammatory bowel disease (IBD) persists with speculation that deleterious effects are mediated through intestinal microbes. ObjectivesTo compare IBD characteristics and changes in the intestinal microbiome (IM) at diagnosis in children with and without lactose malabsorption (LM). MethodsA cross-sectional cohort of children (8–17 y of age) diagnosed with Crohn’s disease [n = 149 (63%)] or ulcerative colitis (n = 86) that had undergone lactose breath hydrogen testing was evaluated. The IM of mucosal luminal aspirates was profiled at the time of diagnosis using 16S ribosomal ribonucleic acid gene amplicon sequencing of the V6 hypervariable region. ResultsOf the 235 children, 61 (26%) had LM. Microbial characterization yielded differences in bacterial differential abundance between children who could and could not absorb lactose, which varied by intestinal site and between subtypes of IBD. There were no differences in the ages [13.2 ± 3.0 y (mean ± standard deviation) compared with 12.7 ± 3.4 y; P = 0.25], sex (P = 0.88), extent of disease involvement or severity of disease at presentation (P = 0.74) when comparing those that could or could not absorb lactose nor was there a difference in the need for initiation of biological agents (P = 0.43) during 2 y of follow-up. ConclusionsLM does not affect the clinical presentation or outcomes of children with IBD. However, this study establishes that a single nonabsorbed fermentable food product can alter the IM in both a regional and disease-specific manner. As we continue to learn more about the pathophysiology of IBD and the role of the IM in disease onset and progression, it would be of benefit to examine the impact of other potential fermentable nutrients and their products on IBD outcomes.

Intestinal microbiome as a diagnostic marker of coronary artery disease: a systematic review and meta-analysis

Background: The intestinal microbiome has been recently linked to several metabolic and chronic disorders, one of which is coronary artery disease (CAD). Our study aimed to analyze the intestinal microbiome of CAD patients and assess the eligibility of dysbiosis as a diagnostic marker of CAD. Methods: PubMed, Scopus, Embase, and Web of Science were searched using terms, such as ‘CAD’ and ‘microbiome’. Only observational controlled studies were included. R version 4.2.2 was used for the analysis. Results: A significant association was found between the CAD group and increased Simpson and Shannon Indices compared with the control group (MD=0.04, 95% CI=0.03–0.05, and MD=0.11, 95% CI=0.01–0.22, respectively). Our analysis yielded a statistically significant association between the CAD group and increased Prevotella genus (MD=13.27, 95% CI=4.12–22.42, P-value=0.004), Catenibacterium genus (MD=0.09, 95% CI=0.09–0.10), Pseudomonas genus (MD=0.54, 95% CI=0.29–0.78, P-value), and Subdoligranulum (MD=−0.06, 95% CI=−0.06 to −0.06) compared with the control group. Another significant association was detected between the CAD group and decreased Bacteroides vulgatus and Bacteroides dorei (MD=−10.31, 95% CI=−14.78 to −5.84, P-value &lt;0.00001). Conclusion: Dysbiosis is an acceptable diagnostic marker of CAD. Decreased B. dorei and B. vulgatus among CAD patients suggests a protective role of these bacteria. Future clinical trials are necessary to investigate the potential benefit of supplementation of these bacteria in treating or preventing CAD.

Intestinal Microbiome and Acute Rejection of the Transplanted Kidney: Results of Single-Center, Case-Control Study

Intestinal Microbiome and Acute Rejection of the Transplanted Kidney: Results of Single-Center, Case-Control Study

Impact of microplastics pollution on ciprofloxacin bioaccumulation in the edible mussel (Perna viridis): implications for human gut health risks

Antibiotics and microplastics are prevalent pollutants in mariculture. Consuming contaminated bivalves can potentially endanger human health, but the impact of microplastics on antibiotics bioaccumulation in bivalves and the related health risks to consumer health risks is not fully understood. We obtained bivalves from a mariculture farm and set up exposure scenarios with ciprofloxacin (1μg/L) alone, microplastics (0.6mg/L) alone, or their combination on mussels for 2-weeks. We investigated ciprofloxacin accumulation and analyzed the effects of these pollutants on detoxification and intestinal microbiome changes. Furthermore, potential food safety hazards related to ingestion of antibiotic-tainted bivalves were also assessed. We found that the accumulation of the ciprofloxacin in bivalves was significantly aggravated by the presence of microplastics. There was a significant increase in the production of antioxidant substances in the host's haemolymph, and an enhanced synthesis of antioxidants by the predicted metabolic functions of the intestinal microbiome. Concomitantly, microplastics exacerbated intestinal dysfunction, with a reduction in beneficial Spirochaetes and an increase in pathogenic bacteria Treponema, which may lead to deterioration of detoxification in the host. Additionally, an assessment of human gut health risks was conducted on the residual ciprofloxacin in bivalves combined with human consumption habits. The estimated target hazard quotients and cancer risk were below safety thresholds, directly consuming contaminated bivalves poses little toxicity. However, with raw mussels consumption, the dietary exposure doses of ciprofloxacin to human gut microbiome exceeded minimal selective concentrations for resistance. This could promote the growth of potentially resistant bacteria, indicating a risk of antibiotic resistance.

Microalgae as feed additives in poultry: A review on the health-promoting effects

This review explores the effects of the inclusion of microalgal biomass in feed on the health of poultry (broilers and laying hens). Microalgae have emerged as a promising feed additive, valued not only for their rich nutritional profile, but also for their bioactive substances. Bioactive compounds, such as phenolics, polyunsaturated fatty acids, oligosaccharides and carotenoids, exhibit antioxidant, anti-inflammatory, antibacterial, and antiviral functions, which hold promise for promoting poultry health. With the ban on prophylactic antibiotic use in feed, microalgal biomass emerges as an innovative feed additive to enhance growth performance and prevent health issues in poultry. This review extensively explains the critical health parameters of poultry, including histology of the intestinal tract, intestinal permeability, immunity, antioxidant status and prebiotic effects on the intestinal microbiome. Furthermore, it offers valuable insights into the inclusion of microalgae in poultry feed, promoting these health parameters. It concludes with suggestions for further research and practical recommendations on how to improve poultry health using microalgal biomass.

The Role of Next-Generation Sequencing (NGS) in the Relationship between the Intestinal Microbiome and Periprosthetic Joint Infections: A Perspective.

Periprosthetic joint infections are still a challenge in orthopedics and traumatology. Nowadays, genomics comes to the aid of diagnosis and treatment, in addition to traditional methods. Recently, a key role of the intestinal microbiota has been postulated, and great efforts are aimed at discovering its interconnection, which shows to be at different levels. Firstly, the gut microbiome influences the immune system through the gut-associated lymphoid tissue (GALT). A balanced microbiome promotes a strong immune response, which is essential to prevent all local and systemic infections, including PJI. Thus, a dysbiosis, i.e., the disruption of this system, leads to an imbalance between the various strains of microorganisms co-existing in the gut microbiome, which can result in a weakened immune system, increasing susceptibility to infections, including PJI. Additionally, the dysbiosis can result in the production of pro-inflammatory mediators that enter the systemic circulation, creating a state of chronic inflammation that can compromise the immune system's ability to fend off infections. Furthermore, the microbiome maintains the integrity of the gut barrier, preventing the translocation of harmful bacteria and endotoxins into the bloodstream; dysbiosis can compromise this protective "wall". In addition, the gut microbiome may harbor antibiotic-resistance genes; during antibiotic treatment for other infections or prophylaxis, these genes may be transferred to pathogenic bacteria, making the treatment of PJI more difficult. In this complex landscape, next-generation sequencing (NGS) technology can play a key role; indeed, it has revolutionized the study of the microbiome, allowing for detailed and comprehensive analysis of microbial communities. It offers insights into the functional potential and metabolic capabilities of the microbiome, studies the collective genome of the microbiome directly from environmental samples sequencing DNA without isolating individual organisms, analyzes the RNA transcripts to understand gene expression and functional activity of the microbiome, analyzes the RNA transcripts to understand gene expression and functional activity of the microbiome, investigates the metabolites produced by the microbiome and studies the entire set of proteins produced by the microbiome. NGS technology, the study of the micromyoma and its implications in the field of orthopedic trauma are innovative topics on which few publications are yet to be found in the international scientific literature. The costs are still high, the focus of research is maximum, and it will certainly change our approach to infections. Our study is an up-to-date review of the hot topic application of NGS in the study and investigation of periprosthetic infections and the microbiome.

Understanding the role of the human gut microbiome in overweight and obesity.

The gut microbiome may be related to the prevalence of overweight and obesity, but high interindividual variability of the human microbiome complicates our understanding. Obesity often occurs concomitantly with micronutrient deficiencies that impair energy metabolism. Microbiota composition is affected by diet. Host-microbiota interactions are bidirectional. We propose three pathways whereby these interactions may modulate the gut microbiome and obesity: (1) ingested compounds or derivatives affecting small intestinal transit, endogenous secretions, digestion, absorption, microbiome balance, and gut barrier function directly affect host metabolism; (2) substrate availability affecting colonic microbial composition and contact with the gut barrier; and (3) microbial end products affecting host metabolism. The quantity/concentration, duration, and/or frequency (circadian rhythm) of changes in these pathways can alter the gut microbiome, disrupt the gut barrier, alter host immunity, and increase the risk of and progression to overweight and obesity. Host-specific characteristics (e.g., genetic variations) may further affect individual sensitivity and/or resilience to diet- and microbiome-associated perturbations in the colonic environment. In this narrative review, the effects of selected interventions, including fecal microbiota transplantation, dietary calorie restriction, dietary fibers and prebiotics, probiotics and synbiotics, vitamins, minerals, and fatty acids, on the gut microbiome, body weight, and/or adiposity are summarized to help identify mechanisms of action and research opportunities.

The disturbance of intestinal microbiome caused by the novel duck reovirus infection in Cherry Valley ducklings can induce intestinal damage

Novel duck reovirus disease is an infectious disease mainly caused by novel duck reovirus (NDRV), which is characterized by spleen necrosis and persistent diarrhea in ducks. However, the pathogenic mechanism of NDRV infection in Cherry Valley ducks remains unclear. To investigate the distribution of NDRV in the intestines of Cherry Valley ducks, intestinal morphogenesis, intestinal permeability, inflammatory cytokines, and the expression of tight junction proteins (TJPs), we introduced NDRV via intramuscular infection. The diversity and composition of ileum flora and content of short-chain fatty acids (SCFAs) were analyzed using Illumina MiSeq sequencing. The relationship between changes in the intestinal microbial community and intestinal damage in Cherry Valley ducks infected with NDRV was also assessed to offer new insights into the pathogenesis of NDRV and intestinal flora composition. The results showed that intestinal inflammation and barrier dysfunction occurred following NDRV infection. Additionally, a significant reduction in dominant bacterial species and a decrease in SCFA content within the intestinal microbiota led to weakened colonization resistance and the enrichment of opportunistic pathogens, exacerbating intestinal damage post-NDRV infection. Notably, TJPs and inflammatory cytokine disruptions were linked to a decline in SCFA-producing bacteria and an accumulation of pathogenic bacteria. In summary, changes in the ileum intestinal flora and disruptions to the intestinal barrier were associated with NDRV infection. Consequently, disturbances in intestinal flora caused by NDRV infection can lead to intestinal damage. These findings may offer us a new perspective, targeting the gut microbiota to better understand the progression of NDRV disease and investigate its underlying pathogenesis.

Endoscopic brush sampling identifies mucosa associated microbiota in colorectal adenomas

The intestinal microbiome plays a crucial role in colorectal adenomas and the mucosa associated microbiota are thought to play a more critical role in interactions with the host immune system. Current omics approaches, offer a holistic assessment of the gut microbiome and the human host interaction. To enhance the value of data from these sequencing methods, appropriate sample collection is vital. We evaluated the potential use of endoscopic brush samples for mucosal microbiota analysis in colorectal adenomas and compared it with direct adenoma tissue sequencing in terms of microbial gene sequencing. The results showed a significant increase in microbial diversity in samples collected by the endoscopic brush, which did not interfere with pathological biopsy. This study found that utilizing endoscopic brush sampling for the microbiome analysis of colorectal adenomas offers several advantages over the direct examination of microbiomes within tumor tissues, including the capacity to accurately collect gut microbiome from different locations in the intestine, circumventing interference from tissue genes, providing more abundant microbial data and enabling inclusion of small adenomas without disrupting pathological biopsies.

Inhalation of 2,2′,5,5′-tetrachlorobiphenyl (PCB52) causes changes to the gut microbiome throughout the gastrointestinal tract

Polychlorinated biphenyls (PCBs), such as PCB52, are hazardous environmental contaminants present in indoor and outdoor environments. Oral PCB exposure affects the colon microbiome; however, it is unknown if inhalation of PCBs alters the intestinal microbiome. We hypothesize that sub-acute inhalation of PCB52 affects microbial communities depending on the location in the (GI) gastrointestinal tract and the local profiles of PCB52 and its metabolites present in the GI tract following mucociliary clearance and biliary or intestinal excretion. Sprague-Dawley rats were exposed via nose-only inhalation 4 h per day, 7 days per week, for 4 weeks to either filtered air or PCB52. After 28 days, differences in the microbiome and levels of PCB52 and its metabolites were characterized throughout the GI tract. PCB52 inhalation altered taxa abundances and predicted functions altered throughout the gut, with most alterations occurring in the large intestine. PCB52 and metabolite levels varied across the GI tract, resulting in differing PCB × microbiome networks. Thus, the presence of different levels of PCB52 and its metabolites in different parts of the GI tract has varying effects on the composition and predicted function of microbial communities. Future studies need to investigate whether these changes lead to adverse outcomes.

Stratification of human gut microbiomes by succinotype is associated with inflammatory bowel disease status

BackgroundThe human gut microbiome produces and consumes a variety of compounds that interact with the host and impact health. Succinate is of particular interest as it intersects with both host and microbiome metabolism. However, which gut bacteria are most responsible for the consumption of intestinal succinate is poorly understood.ResultsWe build upon an enrichment-based whole fecal sample culturing approach and identify two main bacterial taxa that are responsible for succinate consumption in the human intestinal microbiome, Phascolarctobacterium and Dialister. These two taxa have the hallmark of a functional guild and are strongly mutual exclusive across 21,459 fecal samples in 94 cohorts and can thus be used to assign a robust “succinotype” to an individual. We show that they differ with respect to their rate of succinate consumption in vitro and that this is associated with higher concentrations of fecal succinate. Finally, individuals suffering from inflammatory bowel disease (IBD) are more likely to have the Dialister succinotype compared to healthy subjects.ConclusionsWe identified that only two bacterial genera are the key succinate consumers in human gut microbiome, despite the fact that many more intestinal bacteria encode for the succinate pathway. This highlights the importance of phenotypic assays in functionally profiling intestinal microbiota. A stratification based on “succinotype” is to our knowledge the first function-based classification of human intestinal microbiota. The association of succinotype with IBD thus builds a bridge between microbiome function and IBD pathophysiology related to succinate homeostasis.1f3imNYWH_SuaBpDzz9CS6Video